Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OMNICELL, INC. Director's Dealing 2018

Aug 23, 2018

31980_dirs_2018-08-23_d9538279-9bac-4b96-b2f5-3ec858179efc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: OMNICELL, Inc (OMCL)
CIK: 0000926326
Period of Report: 2018-06-19

Reporting Person: LIPPS RANDALL A (Director, Chairman, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-06-19 Common Stock S 9483 $52.0408 Disposed 191265 Direct
2018-06-19 Common Stock M 18154 Acquired 209419 Direct
2018-06-19 Common Stock S 18154 $52.00 Disposed 191265 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-06-19 Stock Options NQ (right to Buy) $25.08 M 18154 Disposed 2025-02-03 Common Stock (18154) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 200748 Direct
Common Stock 361701 Indirect
Common Stock 14549 Indirect

Footnotes

F1: Shares held in trust with Mr. Lipps' wife.

F2: Shares held in trust for the benefit of Mr. Lipps' children.

F3: The price reported in Column 4 is the exact price of $52.00 the shares sold. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan.

F5: The price reported in Column 4 is the Average price of $52.0408. The shares sold between $51.35 to $52.25. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: This amendment is being filed to correct the balance of shares held in trust with the reporting person's wife. This balance was incorrectly reported as 393,228 shares; however, the correct balance is 361,701 shares. As originally reported in a Form 4 filed on June 20, 2017, the reporting person sold 31,527 shares from this trust on June 19, 2017 pursuant to a Rule 10b5-1 trading plan. However, due to an administrative error, this reported sale was not correctly reflected in the balance of shares held in this trust in all Form 4s filed by the reporting person following the sale from July 28, 2017 through June 20, 2018.

F7: Reflects a transfer of 1,000 shares in June 2018 from this trust directly to the reporting person's child (who is no longer a minor) as the reporting person no longer has a reportable beneficial interest in such shares.

F8: This reflects the correct starting balance of directly owned shares which was incorrectly reported due to an administrative error in the original Form 4,filed on June 20, 2018.